129 related articles for article (PubMed ID: 30264682)
21. Cynaropicrin is dual regulator for both degradation factors and synthesis factors in the cartilage metabolism.
Masutani T; Tanaka YT; Kojima H; Tsuboi M; Hara A; Niwa M
Life Sci; 2016 Aug; 158():70-7. PubMed ID: 27373423
[TBL] [Abstract][Full Text] [Related]
22. Altholactone Inhibits NF-κB and STAT3 Activation and Induces Reactive Oxygen Species-Mediated Apoptosis in Prostate Cancer DU145 Cells.
Jiang C; Masood M; Rasul A; Wei W; Wang Y; Ali M; Mustaqeem M; Li J; Li X
Molecules; 2017 Feb; 22(2):. PubMed ID: 28178219
[TBL] [Abstract][Full Text] [Related]
23. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells.
Zhang L; Cheng X; Gao Y; Bao J; Guan H; Lu R; Yu H; Xu Q; Sun Y
Food Funct; 2016 Jan; 7(1):315-25. PubMed ID: 26442630
[TBL] [Abstract][Full Text] [Related]
24. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of cynaropicrin and related sesquiterpene lactones from leaves of artichoke (Cynara scolymus L.) on induction of iNOS in RAW264.7 cells and its high-affinity proteins.
Matsumoto T; Nakashima S; Nakamura S; Hattori Y; Ando T; Matsuda H
J Nat Med; 2021 Mar; 75(2):381-392. PubMed ID: 33484417
[TBL] [Abstract][Full Text] [Related]
26. Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells.
D'Agostino M; Voce P; Celano M; Sponziello M; Moretti S; Maggisano V; Verrienti A; Durante C; Filetti S; Puxeddu E; Russo D
Thyroid; 2012 Feb; 22(2):138-44. PubMed ID: 22191389
[TBL] [Abstract][Full Text] [Related]
27. Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells.
Allegri L; Capriglione F; Maggisano V; Damante G; Baldan F
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360846
[TBL] [Abstract][Full Text] [Related]
28. 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer.
Clinckspoor I; Verlinden L; Overbergh L; Korch C; Bouillon R; Mathieu C; Verstuyf A; Decallonne B
J Steroid Biochem Mol Biol; 2011 Mar; 124(1-2):1-9. PubMed ID: 21182945
[TBL] [Abstract][Full Text] [Related]
29. Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer.
Lv Z; Yan X; Lu L; Su C; He Y
J Bioenerg Biomembr; 2018 Aug; 50(4):263-270. PubMed ID: 29687367
[TBL] [Abstract][Full Text] [Related]
30. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
[TBL] [Abstract][Full Text] [Related]
31. Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance.
D'Aprile S; Denaro S; Pavone AM; Giallongo S; Giallongo C; Distefano A; Salvatorelli L; Torrisi F; Giuffrida R; Forte S; Tibullo D; Li Volti G; Magro G; Vicario N; Parenti R
J Transl Med; 2023 Nov; 21(1):780. PubMed ID: 37924062
[TBL] [Abstract][Full Text] [Related]
32. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
[TBL] [Abstract][Full Text] [Related]
33. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.
Wang XM; Liu Y; Fan YX; Liu Z; Yuan QL; Jia M; Geng ZS; Gu L; Lu XB
Cancer Biol Ther; 2018 Jul; 19(7):590-597. PubMed ID: 29561707
[TBL] [Abstract][Full Text] [Related]
34. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells.
de Souza Grinevicius VM; Kviecinski MR; Santos Mota NS; Ourique F; Porfirio Will Castro LS; Andreguetti RR; Gomes Correia JF; Filho DW; Pich CT; Pedrosa RC
J Ethnopharmacol; 2016 Aug; 189():139-47. PubMed ID: 27178634
[TBL] [Abstract][Full Text] [Related]
35. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
36. The Hepatotoxicity of Alantolactone and Germacrone: Their Influence on Cholesterol and Lipid Metabolism in Differentiated HepaRG Cells.
Zárybnický T; Matoušková P; Skálová L; Boušová I
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32521813
[TBL] [Abstract][Full Text] [Related]
37. Deoxyelephantopin impairs growth of cervical carcinoma SiHa cells and induces apoptosis by targeting multiple molecular signaling pathways.
Farha AK; Dhanya SR; Mangalam SN; Geetha BS; Latha PG; Remani P
Cell Biol Toxicol; 2014 Dec; 30(6):331-43. PubMed ID: 25260383
[TBL] [Abstract][Full Text] [Related]
38. Small interfering RNA (siRNA) against Slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin.
Pan Y; Liu P; Chen D; Dou L
Cancer Biomark; 2017; 18(4):357-366. PubMed ID: 28128736
[TBL] [Abstract][Full Text] [Related]
39. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
[TBL] [Abstract][Full Text] [Related]
40. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]